GUANFACINE 1 MG TABLET
For 30 tablets
Pharmacies pay
$4.40 filed
30 × $0.14657 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$17.01 filed
30 × $0.56698 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
3.9× estimated
Medicare paid 3.9× what pharmacies pay.
Part D averages every strength and form sold under “Guanfacine HCl” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$10.06 estimated
$4.40 + $0.66 (15%) + $5.00 fee per fill = $10.06
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
GUANFACINE 1 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “guanfacine hydrochloride”, “gaunfacine” and “guanfacine”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as tablet and its route as oral.
FDA lists 15 labelers (the companies named on the label) for its NDCs, among them Actavis Pharma, Inc., Major Pharmaceuticals and TWi Pharmaceuticals, Inc.
FDA’s Established Pharmacologic Class for it is Central alpha-2 Adrenergic Agonist.
The NADAC file of 2026-10-14 prices it under 17 NDCs (National Drug Codes); the FDA directory lists 15 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $4.40 for 30 tablets (30 × $0.14657 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 15 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Actavis Pharma, Inc. | 1 | $0.14657 per EA filed |
| Advagen Pharma Ltd | 1 | $0.14657 per EA filed |
| Ajanta Pharma USA Inc. | 1 | $0.14657 per EA filed |
| American Health Packaging | 1 | $0.14657 per EA filed |
| Amneal Pharmaceuticals LLC | 1 | $0.14657 per EA filed |
| Amneal Pharmaceuticals of New York LLC | 1 | $0.14657 per EA filed |
| Aurobindo Pharma Limited | 1 | $0.14657 per EA filed |
| Chartwell RX, LLC | 1 | $0.14657 per EA filed |
| Epic Pharma, LLC | 1 | $0.14657 per EA filed |
| Major Pharmaceuticals | 1 | $0.14657 per EA filed |
| Precision Dose, Inc. | 1 | $0.14657 per EA filed |
| TWi Pharmaceuticals, Inc. | 1 | $0.14657 per EA filed |
| Unichem Pharmaceuticals (USA), Inc. | 1 | $0.14657 per EA filed |
| XIROMED, LLC | 1 | $0.14657 per EA filed |
| i3 Pharmaceuticals, LLC | 1 | $0.14657 per EA filed |
| Not listed as a package in the FDA directory | 2 | $0.14657 per EA filed |
All 17 NDCs, with labeler and price
- 00591-0444-01 · Actavis Pharma, Inc. · $0.14657 per EA · eff. 2026-09-23 filed
- 00904-7140-04 · Major Pharmaceuticals · $0.14657 per EA · eff. 2026-09-23 filed
- 24979-0198-01 · TWi Pharmaceuticals, Inc. · $0.14657 per EA · eff. 2026-09-23 filed
- 27241-0242-01 · Ajanta Pharma USA Inc. · $0.14657 per EA · eff. 2026-09-23 filed
- 29300-0458-01 · Unichem Pharmaceuticals (USA), Inc. · $0.14657 per EA · eff. 2026-09-23 filed
- 42806-0048-01 · Epic Pharma, LLC · $0.14657 per EA · eff. 2026-09-23 filed
- 53746-0711-01 · Amneal Pharmaceuticals of New York LLC · $0.14657 per EA · eff. 2026-09-23 filed
- 59651-0840-01 · Aurobindo Pharma Limited · $0.14657 per EA · eff. 2026-09-23 filed
- 60687-0710-11 · not listed as a package in the FDA directory · $0.14657 per EA · eff. 2026-09-23 filed
- 60687-0710-21 · American Health Packaging · $0.14657 per EA · eff. 2026-09-23 filed
- 62135-0727-90 · Chartwell RX, LLC · $0.14657 per EA · eff. 2026-09-23 filed
- 65162-0711-10 · Amneal Pharmaceuticals LLC · $0.14657 per EA · eff. 2026-09-23 filed
- 68094-0065-59 · not listed as a package in the FDA directory · $0.14657 per EA · eff. 2026-09-23 filed
- 68094-0065-62 · Precision Dose, Inc. · $0.14657 per EA · eff. 2026-09-23 filed
- 70700-0301-01 · XIROMED, LLC · $0.14657 per EA · eff. 2026-09-23 filed
- 72319-0018-04 · i3 Pharmaceuticals, LLC · $0.14657 per EA · eff. 2026-09-23 filed
- 72888-0123-01 · Advagen Pharma Ltd · $0.14657 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
9 other products in the NADAC file share an FDA nonproprietary name with GUANFACINE 1 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| GUANFACINE 1 MG TABLET this page | $0.14657 per EA filed | $0.56698 per EA filed |
| GUANFACINE 2 MG TABLET | $0.26727 per EA filed | $0.56698 per EA filed |
| GUANFACINE HCL ER 1 MG TABLET | $0.13256 per EA filed | $0.83991 per EA filed |
| GUANFACINE HCL ER 2 MG TABLET | $0.14767 per EA filed | $0.83991 per EA filed |
| GUANFACINE HCL ER 3 MG TABLET | $0.16584 per EA filed | $0.83991 per EA filed |
| GUANFACINE HCL ER 4 MG TABLET | $0.17621 per EA filed | $0.83991 per EA filed |
| INTUNIV ER 1 MG TABLET | $9.38648 per EA filed | We don’t know yet |
| INTUNIV ER 2 MG TABLET | $9.26199 per EA filed | We don’t know yet |
| INTUNIV ER 3 MG TABLET | $9.29231 per EA filed | We don’t know yet |
| INTUNIV ER 4 MG TABLET | $9.26984 per EA filed | We don’t know yet |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 17 NDCs’ NADAC prices is $0.14657 per EA filed.
Of the 22 other products in FDA’s Central alpha-2 Adrenergic Agonist class priced per EA, 13 have a higher middle NADAC price and 9 a lower one. The one in the middle is GUANFACINE HCL ER 3 MG TABLET, at $0.16584 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $17.01 for 30 tablets, at an average of $0.56698 per EA in 2024 (2024-01-01 to 2024-12-31) for “Guanfacine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 117,298 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for GUANFACINE 1 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Guanfacine HCl / Guanfacine HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic class
Related in the same class
- TIZANIDINE HCL 2 MG CAPSULE
- TIZANIDINE HCL 2 MG TABLET
- CLONIDINE HCL 0.1 MG TABLET
- CLONIDINE 0.1 MG/DAY PATCH
- JAVADIN 0.02 MG/ML SOLUTION